Safety and Effectiveness of a Peripheral Rheolytic Thrombectomy Catheter in ST-Segment Elevation Myocardial
Giuseppe Giacchi1, Agnese Bentivegna1, Ida Logatto1
1Cardiology Department, Cardio-Neuro-Vascular Institute, Giovanni Paolo II Hospital, ASP 7 Ragusa, 97100 Ragusa, Italy.
Insights
This case series shows the AngioJet Solent Dista catheter effectively reduced thrombus in high-thrombus-burden coronary lesions for ST-segment elevation myocardial infarction patients. Mid-term follow-up revealed no angina, suggesting a promising treatment option.
Area of Science:
- Interventional Cardiology
- Cardiovascular Thrombosis
- Medical Device Technology
Background:
- Percutaneous coronary intervention for highly thrombotic lesions presents significant challenges.
- High thrombus burden is associated with poorer acute and long-term clinical outcomes.
- Novel thrombectomy devices are needed to improve treatment efficacy.
Abstract:
Percutaneous treatment of highly thrombotic coronary lesions is demanding, due to worse acute and long-term clinical outcomes. In this report, we describe a case series of six patients with ST-segment elevation myocardial infarction and high-thrombus-burden coronary lesions. All patients were treated with the AngioJet Solent® Dista catheter, a rheolytic thrombectomy device designed for peripheral use. The catheter effectively reduced the thrombus burden in all cases, achieving satisfactory final angiographic results. One case of no-reflow was observed following lesion dilatation prior to thrombectomy, but no other major in-hospital adverse events occurred. At mid-term follow-up, all patients remained free from angina. These preliminary findings suggest that this approach could represent a promising option for managing highly thrombotic coronary lesions, but further studies with larger populations and long-term follow-up are needed to confirm these results.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care


